Amai Proteins has a total of 23 patents globally, out of which no patents have been granted. Of these 23 patents, more than 86% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Amai Proteins.
SeLux Diagnostics has a total of 177 patents globally, out of which 25 have been granted. Of these 177 patents, more than 55% patents are active. The United States of America is where SeLux Diagnostics has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States
ImmunoMet Therapeutics has a total of 100 patents globally, out of which 67 have been granted. Of these 100 patents, more than 79% patents are active. Parallelly, Korea (South) seems to be the main focused R&D centre and also United States Of America is the origin country of ImmunoMet Therapeutics.
Oncocross has a total of 102 patents globally, out of which 35 have been granted. Of these 102 patents, more than 79% patents are active. Korea (South) is where Oncocross has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, Korea (South) seems to
Voronoi has a total of 90 patents globally, out of which 3 have been granted. Of these 90 patents, more than 68% patents are active. Korea (South) is where Voronoi has filed the maximum number of patents, followed by Japan and United States of America. Parallelly, Korea (South) seems to
Flaskworks has a total of 74 patents globally, out of which 5 have been granted. Of these 74 patents, more than 94% patents are active. The United States of America is where Flaskworks has filed the maximum number of patents. Parallelly, United States of America seems to be the main
Maze Therapeutics has a total of 21 patents globally, out of which no patents have been granted. Of these 21 patents, more than 95% patents are active. Canada is where Maze Therapeutics has filed the maximum number of patents, followed by Australia and United States of America. Parallelly, United States
Kriya Therapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 90% patents are active. Canada is where Kriya Therapeutics has filed the maximum number of patents, followed by Australia and Europe. Parallelly, United States of America seems
Inflammatix has a total of 34 patents globally, out of which 5 have been granted. Of these 34 patents, more than 79% patents are active. United States of America is where Inflammatix has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems
Hibercell has a total of 115 patents globally, out of which 31 have been granted. Of these 115 patents, more than 80% patents are active. United States of America is where Hibercell has filed the maximum number of patents, followed by Europe and Hong Kong (S.A.R.). Parallelly, United States of
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.